Risk of type 2 diabetes attributable to C-reactive protein and other risk factors.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 17623828.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To calculate the population-attributable risk (PAR) of C-reactive protein (CRP) and other risk factors for type 2 diabetes. The Rotterdam Study is a population-based, prospective follow-up study among 7,983 participants aged > or = 55 years. Risk factors including serum CRP were determined at baseline. Participants with diabetes at baseline were excluded, and the cohort was followed for a mean of 10.8 years. The hazard ratio (HR) and PAR for diabetes were computed for all studied risk factors. Serum CRP > 1 mg/l (HR 1.67, PAR 0.33), BMI > 25 kg/m2 (HR 2.51, PAR 0.51), waist circumference > 102 for men and > 88 cm for women (HR 1.36, PAR 0.14), current smoking (HR 1.16, PAR 0.03), age > 65 years (HR 1.35, PAR 0.15), and family history of diabetes (HR 1.87, PAR 0.16) were related to diabetes and contributed to the risk of the disease. Serum CRP was a greater contributor to the risk of diabetes in women than in men (PAR values of 0.37 vs. 0.28, respectively). Age and current smoking PARs were not statistically significantly contributing to the risk of diabetes in women. Combined PAR was 0.80 (95% CI 0.74-0.85) for all six studied risk factors and 0.71 (0.64-0.78) for modifiable risk factors (serum CRP, BMI, waist circumference, and current smoking). High CRP is one of the major contributors to the risk of type 2 diabetes. The contribution of modifiable risk factors to the risk of diabetes is considerable.
Medical subject headings
- C-Reactive Protein
- Diabetes Mellitus, Type 2